Advanced Cell Models – Webinars and Online Events

Explore the tools and techniques being used to study diseases in the lab. Discover how advances in cell culture and disease modeling are supporting diagnostic and therapeutic development.

This online event is aimed at those working within academia and pharmaceutical drug development, who want to hear from experts across their field. Focus will be given to the latest advances in small molecule drug discovery and development, biopharma and biotechnology.

Bio-Techne has extensive experience in and offers a strong and diverse portfolio for the generation, maintenance and characterization of organoids and other 3D culture systems such as spheroids.

This exclusive on-demand AMA event grants you unprecedented access to the pioneering expert Prof. Donald Ingber, delving deep into the captivating realm of body-on-a-chip technology– completely free of charge.

Enhance your research by gaining a solid understanding of how to unravel tissue complexity and how to establish an optimized workflow for 3D imaging in your lab.

Traditional organoid culture can present challenges for the downstream analysis of single organoids. In this webinar, Dr. Allysa Stern will discuss a unique workflow that enables clonal organoid development, monitoring of iPSC differentiation over time and automated isolation of single organoids.

Dr. Scott Magness will then present a case related to his group’s work investigating tumor cell heterogeneity through clonal organoid morphology and transcriptomics. He will discuss new approaches using single organoid transcriptomics to evaluate organoids derived from single cells from gastric dysplastic tissues and how this approach might reveal new ways to investigate tumor cell heterogeneity and evasion of some cells from cancer treatments.

This online symposium will explore the tools and techniques being used to study diseases in the lab. Focus will be given to cell culture, organs-on-chips and key modeling strategies, as well as how research advances are enabling researchers to elucidate the underlying biological mechanisms of disease and support diagnostic and therapeutic development.

In this webinar series, speakers describe the development of an in-house 3D drug sensitivity and resistance testing platform, the development of a pipeline to functionally evaluate 3D organoid models from patients with genitourinary tumors, and how to better understand your 3D cell models and make insightful discoveries.

Join the webinar to learn how:

• Liver disease progresses from a dysregulation of metabolism
• Lipid metabolism differs between mice and men and the impact this has on drug development
• Primary human NASH models can evaluate drugs that target metabolism
• NASH models allow the quantitation of lipid droplets, metabolism and fibrosis

In this webinar, we will explore how retinal organoids are used as a platform to assess the safety and efficacy of retinal gene therapy treatments.